EPIC-1042

EPIC-1042 is an orally active PTRF inhibitor. EPIC-1042 disrupts the PTRF/Cavin-1-caveolin-1 interaction and inhibits ubiquitination-mediated proteasomal degradation to preserve TAX1BP1. EPIC-1042 promotes the binding of p62 to PARP1 and p62-mediated degradation of PARP1, impairing base excision repair and MGMT recruitment. EPIC-1042 enhances Mitophagy, reduces ROS, and reduces Apoptosis. EPIC-1042 reduces infarct volume after reperfusion injury and improves neurological and cognitive outcomes. EPIC-1042 can be used for research on ischemic stroke and glioblastoma.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 372180-55-7
  • Fòrmula: C20H26N6
  • Peso molecular:350.46
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00